Genomma Lab Internacional, S.A.B. de C.V. Share Price
Stocks
LAB B
MX01LA010006
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.76 MXN | +1.10% |
|
-0.14% | -17.50% |
| Market Cap | 1.44TCr 84Cr 72Cr 66Cr 63Cr 117.51Cr 7.91TCr 118.5Cr 787.35Cr 306.53Cr 3.88TCr 314.39Cr 307.67Cr 13TCr | P/E 2026 * |
6.39x | P/E 2027 * | 6.65x |
|---|---|---|---|---|---|
| Enterprise Value | 1.81TCr 105.31Cr 91Cr 84Cr 79Cr 147.74Cr 9.94TCr 148.98Cr 989.89Cr 385.39Cr 4.88TCr 395.27Cr 386.82Cr 17TCr | EV / Sales 2026 * |
0.99x | EV / Sales 2027 * | 0.93x |
| Free-Float |
69.07% | Yield 2026 * |
5.42% | Yield 2027 * | 7.44% |
Last Transcript: Genomma Lab Internacional, S.A.B. de C.V.
| 1 day | +1.10% | ||
| 1 week | -0.14% | ||
| Current month | -7.63% | ||
| 1 month | -6.17% | ||
| 3 months | -20.17% | ||
| 6 months | -15.85% | ||
| Current year | -17.50% |
| 1 week | 14.49 |  | 15.05 |
| 1 month | 14.49 | | 16.44 |
| Current year | 14.49 | | 19.48 |
| 1 year | 14.49 | | 23.6 |
| 3 years | 12.39 | | 29.18 |
| 5 years | 12.39 | | 29.18 |
| 10 years | 11.1 | | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 12/04/2023 |
| Director of Finance/CFO | - | 01/12/2015 | |
| Investor Relations Contact | - | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | 01/01/2017 | |
| Chairman | - | 30/10/1996 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.10% | -0.14% | -30.80% | +3.87% | 84Cr | |
| -0.94% | -2.14% | +40.54% | +148.38% | 99TCr | |
| -0.42% | -1.80% | +53.69% | +42.60% | 56TCr | |
| -0.56% | -1.65% | +19.27% | +59.57% | 39TCr | |
| -1.01% | +0.68% | +24.66% | +16.53% | 33TCr | |
| -0.66% | -1.49% | +26.81% | +14.85% | 28TCr | |
| -0.43% | -1.02% | +26.67% | +32.42% | 28TCr | |
| -1.27% | -0.18% | -41.54% | -47.90% | 20TCr | |
| -1.78% | +1.16% | +17.79% | +48.77% | 18TCr | |
| -1.40% | +3.27% | +16.16% | +59.08% | 16TCr | |
| Average | -0.20% | +0.32% | +15.33% | +37.82% | 33.72TCr | |
| Weighted average by Cap. | -0.27% | -0.49% | +29.27% | +65.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.83TCr 106.62Cr 92Cr 85Cr 80Cr 149.57Cr 10TCr 150.83Cr 1TCr 390.18Cr 4.94TCr 400.18Cr 391.63Cr 17TCr | 1.92TCr 111.95Cr 97Cr 89Cr 84Cr 157.04Cr 11TCr 158.36Cr 1.05TCr 409.66Cr 5.19TCr 420.16Cr 411.18Cr 18TCr |
| Net income | 230.8Cr 13Cr 12Cr 11Cr 10Cr 19Cr 1.27TCr 19Cr 126.24Cr 49Cr 622.08Cr 50Cr 49Cr 2.15TCr | 225.08Cr 13Cr 11Cr 10Cr 9.78Cr 18Cr 1.24TCr 19Cr 123.11Cr 48Cr 606.66Cr 49Cr 48Cr 2.1TCr |
| Net Debt | 370.3Cr 22Cr 19Cr 17Cr 16Cr 30Cr 2.03TCr 30Cr 202.54Cr 79Cr 998.07Cr 81Cr 79Cr 3.45TCr | 343.97Cr 20Cr 17Cr 16Cr 15Cr 28Cr 1.89TCr 28Cr 188.14Cr 73Cr 927.09Cr 75Cr 74Cr 3.21TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | 14.76 $ | +1.10% | 38,79,918 |
| 16/26/16 | 14.60 $ | -0.82% | 37,94,656 |
| 15/26/15 | 14.72 $ | +0.55% | 43,20,511 |
| 12/26/12 | 14.64 $ | -1.28% | 36,78,688 |
| 11/26/11 | 14.83 $ | +0.34% | 36,47,872 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LAB B Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition